Overall, the global dural repair market was valued at $365 million in 2021. This is expected to increase over the forecast period at a CAGR of 2.8% to reach $445 million by 2028.

The full report suite on the global market for dural repair includes the allograft, xenograft and synthetic dural repair markets.

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2028, and Historical Data to 2018
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

PROCEDURE NUMBERS

The increasing number of neurosurgical procedures, combined with the increasing population, will drive growth in dural repair procedures using soft tissue devices.

GLOBAL DURAL REPAIR MARKET TRENDS

Xenografts are becoming a routine choice among neurosurgeons for dural repair. They possess intrinsic features, such as biocompatibility, that contribute to favorable clinical outcomes following dural repair. Additionally, they eliminate the need for a secondary surgery to harvest an autograft. Compared to other biologics, such as allografts, xenografts are also priced more competitively. As a result, the market for dural repair is expected to be driven by the growth in xenograft device usage.

GLOBAL DURAL REPAIR MARKET SHARE INSIGHTS

Overall, within the global dural repair market there are three dominant competitors: Integra Lifesciences, Stryker, and Medtronic.

In 2021, Integra LifeSciences was the leading competitor in the global dural repair market. This company offers a line of dural repair products that it sells under the DuraGen® Dural Regeneration Matrix.

GLOBAL DURAL REPAIR MARKET SEGMENTATION SUMMARY

• Allograft Dural Repair Market
• Xenograft Dural Repair Market 
• Synthetic Dural Repair Market 

Research Scope Summary

WHY CHOOSE iDATA?

• • Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

FREE Sample Report